Marc Temmerman

Founded in 2005, ACCO Brands Europe Ltd. is a subsidiary of ACCO Brands Corp. that supplies branded school, office, and consumer products. The company is based in Aylesbury, UK.

ACCO Europe Ltd. supplies branded school, office, and consumer products. The company was founded on June 23, 1987 and is headquartered in Aylesbury, the United Kingdom.

Founded in 1950, ACCO-Rexel Group Services Ltd. is a holding British company that operates through its subsidiaries to manufacture and sell office products. Part of ACCO Brands Corp., the company is based in Aylesbury, UK.

Foundry Innovation & Research 1 Ltd. develops novel therapeutic devices. It has evolved into one of the leading clusters for medical devices globally. The company was headquartered in Dublin, Ireland.

Acertys Group provides medical technology solutions. It provides high acute care, diagnostic care solutions, medical imaging, subacute consumables and accessories, and personal protective equipment. The company was founded in 2007 and is headquartered in Aartselaar, Belgium.

Part of ACCO Brands Corp., ACCO Brands France SAS is a French company that provides business and management consulting services. The company is based in Rueil-Malmaison, France. The CEOs of the company are Christopher Neil Hopkinson and Hervé Picault.

Gimv (Private Equity) is a Private Equity firm, a subsidiary of Gimv NV (XB: GIMB) founded in 1980. Gimv (Private Equity) is headquartered in Antwerp, Belgium.

Part of ACCO Brands Corp., LEITZ ACCO Brands GmbH & Co KG is a wholesaler of cardboard, paper, stationery, office supplies, books, magazines, and newspapers. The company is based in Stuttgart, Germany. The CEOs are Katrin Schuh, Ard-Jen Spijkervet, Christopher Neil Hopkinson. The German company was founded in 1896 by Louis Leitz.

Part of ACCO Brands Corp., Esselte SAS is a wholesaler of household goods. The company is based in Rueil-Malmaison, France.

Part of ACCO Brands Corp., ACCO GmbH is a German company that provides brokerage services in the sale of cardboard, stationery, paper, office supplies, gifts and promotional items. The company is based in Stuttgart, Germany. The CEOs of the company are Ard-Jen Spijkervet, Christopher Neil Hopkinson, Katrin Schuh.

Part of Kotobuki Realty Co., Ltd., NOBO Group Ltd. operates as a holding British company that manufactures and sells presentation and office products through its subsidiary. The company is based in Aylesbury, UK.

Esselte AS produces and trades office equipment and supplies. Its products include lamination machines, scissors, envelops, printing paper, frames, nailing guns, adhesives, staplers, and other office staples. The company was founded on May 31, 1961 and is headquartered in Oslo, Norway.

Esselte Sverige AB manufactures and supplies office and graphic products. It provides news features and efficient designs for both workplace and home office. The firm's brands include Jopa, Photo-Safe, Esselte Dataline, Memo, and Copy-Safe. The company was founded on May 7, 2002 and is headquartered in Solna, Sweden.

ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland.

Complix NVengages in the development of biopharmaceutical company developing Alphabodies, a pipeline of transformative protein therapeutics. The Company is currently focusing its internal research and development activities on oncology and autoimmune diseases. Its therapeutic Alphabodies focuses on the treatment of autoimmune diseases, such as rheumatoid arthritis, psoriasis and multiple sclerosis, and infectious diseases, and viral diseases such as influenza, HIV, and RSV. The company was founded by Mark Vaeck and Ignace Lasters in 2008 and is headquartered in Diepenbeek, Belgium.

PamGene BV provides biopharmaceutical products and clinical settings. It also provides PamChip biomarkers, such as tyrosine kinases, serine/threonine kinases, nuclear receptors, and reagent kits. The firm provides BioNavigator, a software tool for interpretation of PamChip measurements, as well as for performing data analysis for various PamChip experiments; and Evolve that enables data capture and analysis, as well as for the export of data into third party software formats. The company was founded by Tim Kievits in December 1999 and is headquartered in 's-Hertogenbosch, the Netherlands.

PamGene is a biomarker company, focused on opening up new opportunities for the development of Personalized Medicine (pre-clinical, translational and clinical). Most of PamGene's projects are in oncology and many of these involve medicines that inhibit or modulate cellular kinases and kinase pathways. The firm collaborators apply its technologies for biomarker research in several other diseases and fields of expertise such as the Central Nervous System, the Cardiovascular area, Immunology and Obesity. PamGene's technology offers a faster and lower risk route for discovery and development of clinically useful biomarkers and uses cell lines and retrospective patient sample collection testing.

deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium.

CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium.

Xantos AG is a functional biology and drug discovery company developing biopharmaceuticals in the areas of cancer and metabolic diseases. Its business model is to develop drug discovery pipelines based on the validated targets and leads generated by its proprietary through target identification and validation system and to form indication specific joint research and development collaborations with pharmaceutical and biotechnology companies. It also offers customers its proprietary technology and cDNA/siRNA screening tools for research service deals. The company is headquartered in Munich, Germany.

FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen.

JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany.

Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium.

Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.

Part of ACCO Brands Corp., Leitz Holding GmbH is an investment holding German company. The company is based in Stuttgart, Germany. The CEOs of the company are Ard-Jen Spijkervet, Katrin Schuh, Walter Joe Thomas.